Squarepoint
ORMP icon

Squarepoint’s Oramed Pharmaceuticals ORMP Stock Holding History

Squarepoint’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58,272
Closed -$166K – 4771
2025
Q4 		$166K Buy
58,272
+28,406
+95% +$73.3K ﹤0.01% 3929
2025
Q3 		$78.8K Sell
29,866
-16,204
-35% -$35.8K ﹤0.01% 4157
2025
Q2 		$104K Sell
46,070
-1,449
-3% -$3.2K ﹤0.01% 4160
2025
Q1 		$102K Sell
47,519
-6,920
-13% -$16K ﹤0.01% 4217
2024
Q4 		$132K Sell
54,439
-28,916
-35% -$68.7K ﹤0.01% 4623
2024
Q3 		$203K Buy
83,355
+1,597
+2% +$3.89K ﹤0.01% 3681
2024
Q2 		$210K Sell
81,758
-7,367
-8% -$17.5K ﹤0.01% 3632
2024
Q1 		$260K Sell
89,125
-28,151
-24% -$78.7K ﹤0.01% 3480
2023
Q4 		$271K Buy
117,276
+64,432
+122% +$138K ﹤0.01% 3435
2023
Q3 		$138K Buy
52,844
+18,679
+55% +$58.8K ﹤0.01% 3510
2023
Q2 		$122K Buy
+34,165
New +$110K ﹤0.01% 3325
2022
Q3 		– Sell
-116,065
Closed -$532K – 3309
2022
Q2 		$532K Buy
+116,065
New +$620K ﹤0.01% 1983
2022
Q1 		– Sell
-39,433
Closed -$563K – 3331
2021
Q4 		$563K Buy
+39,433
New +$824K ﹤0.01% 2063
2021
Q1 		– Sell
-30,427
Closed -$129K – 3485
2020
Q4 		$129K Buy
+30,427
New +$99K ﹤0.01% 2661
2018
Q4 		– Sell
-14,500
Closed -$71K – 2160
2018
Q3 		$71K Buy
+14,500
New +$75.3K ﹤0.01% 1907

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Squarepoint's ORMP Position: Q1 2026 in Review

Squarepoint sold out of Oramed Pharmaceuticals (ORMP) in Q1 2026, closing a stake of 58,272 shares — an estimated $166K sold.

Squarepoint first reported a position in ORMP in Q3 2018 and held it in 15 quarters. The position peaked at $563K in Q4 2021. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Squarepoint reported no remaining Oramed Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 58,272 Oramed Pharmaceuticals shares in Q1 2026, an estimated $166K.
  • Squarepoint first reported a position in Oramed Pharmaceuticals in Q3 2018 and held it in 15 quarters.
  • Squarepoint's Oramed Pharmaceuticals position peaked at $563K in Q4 2021.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.